Key Manufacturers Operating in Biologics Market to Hit Lucrative Growth CAGR of 8.25% by 2030

MarkNtel Advisors – Leading Market Research Company found Global Biologics Market is expected to reach 8.25% CAGR Growth By 2030.

This report provides a comprehensive analysis of the Global Biologics Market, with a focus on market size, segmentation, key players, geographical analysis, and growth in the coming years. The expert team of analysts invested considerable time and effort in collecting and analyzing the latest market data, producing a comprehensive and current report that provides valuable insights for decision-makers, including business owners and analysts.

Comprehensive Analysis of the Biologics Market

Base Year: 2023

Forecast Years: 2024-2030

Historical Years: 2019-2022

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure-  – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Scope of the Biologics Market Report:

The Global Biologics Market size is valued at USD 412 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth. Other factors driving the demand for biologics across the global scale include enhanced usage of monoclonal antibodies for disease treatment, innovation & advancement in the healthcare & biotechnology sectors, and to cure diseases, including anemia, rheumatoid arthritis, osteoporosis, Alzheimer’s, etc. Also, diseases like cancer and autoimmune disorders, which pose significant healthcare challenges, underscore the importance of targeted therapeutic interventions, and hence, have been driving the need for biologics over the historical years.

Which prominent factor is expected to drive the Biologics Market during 2024-30?

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

What are the different Segment Available in the Biologics Market?

By Therapeutic Application

  • Oncology- Market Size & Forecast 2019-2030, (USD Million)
  • Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)
  • Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)
  • Diabetes- Market Size & Forecast 2019-2030, (USD Million)
  • Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)
  • Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Drug Class

  • Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)
    • Hormones- Market Size & Forecast 2019-2030, (USD Million)
    • Cytokines- Market Size & Forecast 2019-2030, (USD Million)
  • Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)
  • Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)
  • Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)
  • Vaccines- Market Size & Forecast 2019-2030, (USD Million)
  • Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

  • Microbes- Market Size & Forecast 2019-2030, (USD Million)
  • Humans- Market Size & Forecast 2019-2030, (USD Million)
  • Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific.

Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/global-biologics-market.html

Leading Biologics companies operating in the Market

  • Bristol-Myers Squibb
  • Pfizer
  • Sanofi
  • Janssen Biotech, Inc.
  • Bayer AG
  • Merck & Co.
  • Amgen Inc.
  • Abbott GmbH
  • Novartis
  • AstraZeneca Plc
  • GlaxoSmithKline Biologicals
  • Moderna, Inc.
  • Ferring Pharmaceuticals Inc.
  • Aimmune Therapeutics, Inc.
  • Hoffman La Roche
  • Others.

*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call +1 628 895 8081 +91 120 4278433

Email: sales@marknteladvisors.com